ArticleFrontiers in psychology2025
The stability of IRT parameters under several test equating conditions.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: It is crucial for researchers and test developers to compare results from different test sets (e. g., re-testing, parallel test forms). To ensure comparability, test sets are often linked using anchor items as a common denominator alongside distinct items. To date, most studies on test equating have been limited in scope, typically comparing only absolute numbers of anchor items or focusing on a single IRT model or equating method. Furthermore, previous research has primarily evaluated the absolute deviation of estimated parameters from true parameters. However, in diagnostic contexts, the correlation between these values is often more relevant for ensuring validity and test fairness. Therefore, the aim of this simulation study was to examine the impact of a broad range of key factors on test equating. Methods: We evaluated correlations and recovery indices between predefined true values and values estimated through test equating for three IRT parameters (discrimination, difficulty, and ability). To this end, we varied the equating method (MS, MM, MGM, IRF, TRF), the IRT model (2PL vs. 3PL), guessing probability (0.000-0.250), anchor item proportion (5-25%), test set size (20-80 items), and the discrimination parameters of the anchor items. In addition, we used samples of 25-100 individuals to assess equating quality under challenging conditions as well as samples of 500 and 1,000 individuals to reflect adequate modeling conditions. Results: Low guessing probabilities and high anchor item discrimination parameters strongly improved test equating quality for all three IRT parameters. Recovery of discrimination and ability parameters increased logarithmically with larger test set sizes and higher anchor item proportions, with each of these two factors partially compensating for reductions in the other. While sample sizes below 100 individuals produced inadequate parameter recovery, samples of 100 or 500 individuals were justifiable under certain conditions. However, samples of only 100 individuals carried a slight risk of non-convergence. The choice of the equating method had rather minor effects and the impact of the IRT model was ambivalent. Discussion: These findings highlight the importance of using distractor-free response formats without any guessing probability, anchor items with high discrimination parameters, and large samples to ensure valid test equating. For individual research and test application purposes, we provide a comprehensive data set covering multiple factor levels and a step-by-step simulation guide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.